Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Dementia & Neuropsychologia|December 8, 2017
Early and severe cognitive impairment in multiple sclerosisMaria Fernanda Mendes, Alessandro Finkelsztejn, Sidney Gomes, et al.
Arquivos De Neuro-Psiquiatria|August 19, 2006
[Cerebellar infarction: analysis of 151 patients]Jefferson Rosi, Paulo Geraldo Dorsa de Oliveira, Antônio Carlos Montanaro, et al.
Clinical Drug Investigation|June 2, 2019
Severe Exacerbation of Multiple Sclerosis Following Withdrawal of FingolimodYara D Fragoso, Tarso Adoni, Sidney Gomes, et al.
Arquivos De Neuro-Psiquiatria|May 4, 2011
Restless legs syndrome and multiple sclerosis: a Brazilian multicenter study and meta-analysis of the literatureYára Dadalti Fragoso, Alessandro Finkelsztejn, Sidney Gomes, et al.
Polymers|December 23, 2022
Biotechnological Applications of Nanoencapsulated Essential Oils: A ReviewPatrícia Melchionna Albuquerque, Sidney Gomes Azevedo, Cleudiane Pereira de Andrade, et al.
Microscopy Research and Technique|August 2, 2022
Nanoscale surface dynamics of spatial patterns of polymeric bilayered particles loaded with essential oilRobert Saraiva Matos, Ítalo Carvalho da Costa, Heloisa David Yasumura, et al.
Nanotechnology|June 3, 2021
Microscopy-based infrared spectroscopy as a tool to evaluate the influence of essential oil on the surface of loaded bilayered-nanoparticlesÍtalo Carvalho da Costa, Robert Saraiva Matos, Sidney Gomes de Azevedo, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumabYara Dadalti Fragoso, Paulo Diniz da Gama, Sidney Gomes, et al.
Clinical Neuropharmacology|November 17, 2010
Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosisYara Dadalti Fragoso, Elizabeth Regina Comini Frota, Juarez Silva Lopes, et al.
Multiple Sclerosis and Related Disorders|January 10, 2025
Retraction Notice to "New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19" [Multiple Sclerosis and Related Disorders 57 (2022) 103321]Yara D Fragoso, Sidney Gomes, Marcus Vinicius M Gonçalves, et al.
Pageof 4